These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1111 related items for PubMed ID: 10379472

  • 1. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C, Pelosini I.
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [Abstract] [Full Text] [Related]

  • 2. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M, Bianchi Porro G.
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Role of acid suppressants in prophylaxis of NSAID damage.
    Chan FK, Sung JJ.
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):433-45. PubMed ID: 11403537
    [Abstract] [Full Text] [Related]

  • 8. Treatment and prevention of NSAID induced gastroduodenal mucosal damage.
    Agrawal NM, Saggioro A.
    J Rheumatol Suppl; 1991 Mar; 28():15-8. PubMed ID: 1674754
    [Abstract] [Full Text] [Related]

  • 9. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ, Agrawal NM.
    J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
    [Abstract] [Full Text] [Related]

  • 10. The biochemical protective mechanisms against non-steroidal anti-inflammatory drug induced G-I mucosal damage.
    Rainsford KD.
    Acta Physiol Hung; 1989 Mar; 73(2-3):261-78. PubMed ID: 2512767
    [Abstract] [Full Text] [Related]

  • 11. Acid suppression therapy: where do we go from here?
    Scarpignato C, Pelosini I, Di Mario F.
    Dig Dis; 2006 Mar; 24(1-2):11-46. PubMed ID: 16699262
    [Abstract] [Full Text] [Related]

  • 12. [Antirheumatic drug-induced damage of the gastroduodenal mucosa: approach to prevention].
    Domschke S, Domschke W.
    Internist (Berl); 1986 Oct; 27(10):630-6. PubMed ID: 2878905
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
    Koch M.
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 1():S54-62. PubMed ID: 10379471
    [Abstract] [Full Text] [Related]

  • 17. Options in the treatment and prevention of NSAID-induced gastroduodenal mucosal damage.
    Agrawal NM, Dajani EZ.
    J Rheumatol Suppl; 1990 Feb; 20():7-11. PubMed ID: 1969964
    [Abstract] [Full Text] [Related]

  • 18. Prevention of NSAID-induced GI mucosal injury.
    Gerritz S, Newton WP.
    J Fam Pract; 1997 Feb; 44(2):130-1. PubMed ID: 9040509
    [No Abstract] [Full Text] [Related]

  • 19. New method of inducing intestinal lesions in rats by intraduodenal administration of aspirin.
    Nonoyama K, Nakagawa K, Amagase K, Takeuchi K, Nakamura M, Okabe S.
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S15-22. PubMed ID: 20586859
    [Abstract] [Full Text] [Related]

  • 20. [Prophylaxis and therapy of gastropathy caused by non-steroidal anti-inflammatory drugs].
    László A.
    Orv Hetil; 2002 Jul 07; 143(27):1643-8. PubMed ID: 12180001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.